Discover the forefront of diabetes care, targeting the latest in once-weekly basal insulin therapy, including unique mechanism of action and pharmacokinetic/pharmacodynamic properties. Unpack recent safety and efficacy data. Additionally, hear discussion about basal insulin therapy for patient care and how to best ensure adherence through effective T2D management. Delve into clinical trials outcomes, glycemic control, weight management, and hypoglycemia risks. Engage in essential scientific discourse to shape the future of diabetes treatment. Particpate in this program for an insightful blend of data and practice.
- Provider:Endocrine Society
- Activity Link: https://education.endocrine.org/URL/ENDO24_Diabetes_Enduring
- Start Date: 2024-07-24 05:00:00
- End Date: 2024-07-24 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
- MOC Credit Details: ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Novo Nordisk (Any division) - Amount: 409303.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Endocrinology, Diabetes, and Metabolism
Subscribe
Login
0 Comments
Oldest